Cargando…
Patent Ductus Arteriosus Clinical Trials: Lessons Learned and Future Directions
The identification of an optimal management strategy for the patent ductus arteriosus (PDA) in the context of extreme prematurity remains elusive. Observational studies have reported a persistent association between PDA and neonatal adverse outcomes, but by and large, no clinical trial, to date, has...
Autores principales: | Smith, Aisling, EL-Khuffash, Afif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830584/ https://www.ncbi.nlm.nih.gov/pubmed/33467401 http://dx.doi.org/10.3390/children8010047 |
Ejemplares similares
-
Application of NPE in the assessment of a patent ductus arteriosus
por: van Laere, David, et al.
Publicado: (2018) -
The effect of patent ductus arteriosus treatment with paracetamol on pulmonary vascular resistance
por: Murphy, Claire, et al.
Publicado: (2022) -
Survey highlighting the lack of consensus on diagnosis and treatment of patent ductus arteriosus in prematurity
por: Hundscheid, Tim, et al.
Publicado: (2022) -
Patent ductus arteriosus, bronchopulmonary dysplasia and pulmonary hypertension—a complex conundrum with many phenotypes?
por: EL-Khuffash, Afif, et al.
Publicado: (2023) -
Case of Patent Ductus Arteriosus
por: Harrington, Archibald W.
Publicado: (1914)